Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Completed · Phase 2 · Has a placebo group

Conditions studied: Lateral Canthal Lines

In brief

The purpose of this study is to evaluate the safety and efficacy of RT001 to treat moderate to severe lateral canthal lines in adults and duration of effect.

Key facts

Study ID
NCT00907387
Run by
Revance Therapeutics, Inc.
People needed
72
Starts
2009-04-01
Expected to finish
2009-10-01
Last updated by the study team
2014-01-17

Who can join

Age: 30 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.